Related Experiment Video

Updated: Sep 6, 2025

Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells
08:42

Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells

Published on: January 15, 2018

11.2K

Guilt by association: EcDNA as a mobile transactivator in cancer

Yanfen Zhu1, Liang Gong2, Chia-Lin Wei3

  • 1The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA; International Institutes of Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang 322000, China.

Trends in Cancer
|June 26, 2022
PubMed

Insights

Extrachromosomal DNA (ecDNA) drives cancer by amplifying oncogenes and promoting tumor growth. Understanding ecDNA

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Extrachromosomal DNA (ecDNA) is a known but understudied genetic alteration in cancer.
  • ecDNA harbors amplified oncogenes, correlating with aggressive tumors and poor patient prognosis.
  • The precise mechanisms by which ecDNA influences tumor cell behavior remain largely unknown.

Purpose of the Study:

  • To elucidate the functional role of ecDNA in cancer development and progression.
  • To investigate how ecDNA contributes to tumor aggressiveness and heterogeneity.
  • To explore potential therapeutic strategies targeting ecDNA.

Main Methods:

  • Review of recent scientific literature on ecDNA.
  • Analysis of genetic and molecular data related to ecDNA in cancer.
  • Exploration of emerging technologies for ecDNA research.

Main Results:

  • ecDNA acts as a reservoir for oncogene amplification, driving aggressive cancer phenotypes.
  • ecDNA hubs function as mobile transcriptional enhancers, modulating gene expression via chromatin interactions.
  • Unequal segregation of ecDNA contributes to intratumor heterogeneity and accelerated tumor evolution.

Conclusions:

  • ecDNA is a significant driver of tumor progression and heterogeneity.
  • Targeting ecDNA vulnerabilities presents a promising therapeutic avenue.
  • Advancements in technology are crucial for further understanding and combating ecDNA-driven cancers.
Keywords:
cancer genome variationchromatin interactionsecDNA hubsextrachromosomal circular DNAmobile activatorssuperenhancers

More Related Videos

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.3K
A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers10:49

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers

Published on: September 26, 2019

5.7K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
DNA-only Transposons02:57

DNA-only Transposons

DNA-only transposons are called autonomous transposons since they code for the enzyme transposase that is required for the transposition mechanism. Insertion of transposons can alter gene functions in multiple ways. They can mutate the gene, alter gene expression by introducing a novel promoter or insulator sequence, introduce new splice sites, and change the mRNA transcripts produced, or remodel chromatin structure.
The donor site from where the transposon is excised is either degraded or...
14.7K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K